LONDON (MarketWatch) -- Pfizer Inc. said that the U.K. National Institute for Health and Clinical Excellence has recommended its Champix (varenicline) treatment for use on the National Health Service.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback